GLP-1 use isn't just drastically changing the lives of those, like McDonald, who are on the weight-loss drug. It's changing ...

Integrating with Lilly’s Employer Connect allows Omada to provide another option with transparent net cost for Zepbound ® and enables defined contribution levels from employers, creating a predictable ...

Can the new GLP-1s help prevent cancer before it starts by tackling obesity and all the dysfunctional metabolic pathways that ...

We reviewed popular telehealth and pharmacy options for finding Zepbound online. Here are the top providers for safe access and ongoing support.

Millions of people have used Ozempic, Wegovy, or Mounjaro to lose significant weight or manage their blood sugar. And for ...

A new GLP-1 weight loss drug called survodutide has shown promising results in a phase 3 clinical trial. The drug, which ...

But the growth story may be far from over for this market leader. Lilly recently won approval for its oral weight loss drug, ...

Ozempic, Mounjaro, and Zepbound can drive impressive weight loss, but stopping them is often followed by rapid weight regain. Researchers found that people regain weight faster after quitting these ...

Inconsistent use of some GLP-1 weight-loss medications, like Ozempic and Wegovy, may significantly lessen their effectiveness ...

Eli Lilly said its tirzepatide franchise had another stellar quarter, with Mounjaro bringing in $8.7 billion in sales. Eli Lilly's GLP-1 franchise brought in a total of $12.9 billion in sales in the ...

Foundayo became available on April 9 and has already reached 20,000 patients as Eli Lilly builds its marketing machine for ...

Eli Lilly (LLY) has cemented its status as the world's leading pharmaceutical company as it produced a stellar set of Q1 2026 ...